ATEC
$13.05
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, ima...
Recent News
Alphatec Touts Share Gains, Valence Robot and Improving Cash Flow at Conference (NASDAQ:ATEC)
Executives from Alphatec (NASDAQ:ATEC) outlined their view of the spine surgery market, growth drivers, and recent financial progress during a conference discussion featuring Chief Financial Officer Todd Koning and Vice President of Finance and Head of Investor Relations Robert Judd. The conversati
The Closest Thing to a Time Machine: My Top 3 Reasons I Love Earnings
I was ten years old the first time I saw Back to the Future in a movie theater. It was the summer of 1985. I remember sitting in that red fabric seat, feet barely flat on the floor, popcorn and Coke balanced carefully in my lap – no cup holders back then. The lights dimmed, the projector hummed, and for the next two hours I was somewhere else entirely. There’s a lot to like: the iconic car and soundtrack, the fantastic performances and sharp humor. But the thing that burned into my brain wasn’t
What Does the Street Think About Alphatec Holdings (ATEC)?
Alphatec Holdings, Inc. (NASDAQ:ATEC) is one of the best small-cap stocks with huge growth potential. On TD Cowen cut the price target on Alphatec Holdings, Inc. (NASDAQ:ATEC) to $20 from $27 on January 26, maintaining a Buy rating on the shares after a transfer of coverage. The firm sees the company’s “growth vectors” as not […]
A Decade From Now, You'll Regret Not Buying This 1 Small-Cap Stock
The best long-term winners often start small.
Did ATEC’s Strong Q4 Beat and Reaffirmed 2026 Outlook Just Shift Alphatec Holdings’ Investment Narrative?
In the past week, Alphatec Holdings, Inc. reported Q4 2025 and full-year results showing a narrower net loss of US$21.73 million for the quarter and US$143.36 million for the year, alongside an adjusted EPS of US$0.06 that exceeded consensus expectations on revenue of US$212.93 million. The company also reaffirmed its 2026 outlook, targeting approximately US$890 million in annual revenue and highlighting growing surgeon adoption, higher procedural volumes, and ecosystem advances across...